Literature DB >> 24770797

Serum growth arrest-specific protein 6 levels are elevated in adult-onset Still's disease.

Hyoun-Ah Kim1, Jin-Young Nam, Ju-Yang Jung, Chang-Bum Bae, Jeong-Mi An, Ja-Young Jeon, Bong-Sik Kim, Chang-Hee Suh.   

Abstract

We investigated the growth arrest-specific protein 6 in adult-onset Still's disease. Serums were collected from 52 adult-onset Still's disease patients with follow-up samples of 21 patients. The growth arrest-specific protein 6 levels in adult-onset Still's disease were higher compared to those in the normal controls (25.37±7.71 vs. 19.86±5.01 ng/mL, p<0.001). However, growth arrest-specific protein 6 did not correlate with disease activity. Also, growth arrest-specific protein 6 was not decreased after activity was resolved in the follow-up. The growth arrest-specific protein 6 in adult-onset Still's disease patients were higher than the normal controls. However, growth arrest-specific protein 6 was not correlated with disease activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24770797     DOI: 10.1007/s10067-014-2629-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Preliminary criteria for classification of adult Still's disease.

Authors:  M Yamaguchi; A Ohta; T Tsunematsu; R Kasukawa; Y Mizushima; H Kashiwagi; S Kashiwazaki; K Tanimoto; Y Matsumoto; T Ota
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

2.  Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6.

Authors:  Y Ishimoto; K Ohashi; K Mizuno; T Nakano
Journal:  J Biochem       Date:  2000-03       Impact factor: 3.387

3.  Analysis of Gas6 in human platelets and plasma.

Authors:  Istvan Balogh; Sassan Hafizi; Jonas Stenhoff; Karin Hansson; Björn Dahlbäck
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03-24       Impact factor: 8.311

4.  Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3.

Authors:  P J Godowski; M R Mark; J Chen; M D Sadick; H Raab; R G Hammonds
Journal:  Cell       Date:  1995-08-11       Impact factor: 41.582

5.  Adult Still's disease: manifestations, disease course, and outcome in 62 patients.

Authors:  J Pouchot; J S Sampalis; F Beaudet; S Carette; F Décary; M Salusinsky-Sternbach; R O Hill; A Gutkowski; M Harth; D Myhal
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

6.  Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.

Authors:  K O'Donnell; I C Harkes; L Dougherty; I P Wicks
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

7.  TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus.

Authors:  Chang-Hee Suh; Brendan Hilliard; Sophia Li; Joan T Merrill; Philip L Cohen
Journal:  Arthritis Res Ther       Date:  2010-07-16       Impact factor: 5.156

8.  Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP).

Authors:  Pier Paolo Sainaghi; Laura Collimedaglia; Federica Alciato; Maurizio A Leone; Erinda Puta; Paola Naldi; Luigi Castello; Francesco Monaco; Gian Carlo Avanzi
Journal:  J Neurol Sci       Date:  2008-02-14       Impact factor: 3.181

9.  Adult onset Still's disease and viral infections.

Authors:  J M Wouters; J van der Veen; L B van de Putte; D J de Rooij
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

10.  Adult Onset Still's Disease and Autoinflammation.

Authors:  Petros Efthimiou; L Nandini Moorthy; Clio P Mavragani; Dimitris Skokos; Bruno Fautrel
Journal:  Int J Inflam       Date:  2012-08-29
View more
  1 in total

1.  Modulation of protein S and growth arrest specific 6 protein signaling inhibits pancreatic cancer cell survival and proliferation.

Authors:  Vijaya S Pilli; Arani Datta; Adrianne Dorsey; Bo Liu; Rinku Majumder
Journal:  Oncol Rep       Date:  2020-07-15       Impact factor: 3.906

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.